Skip to main content
Monday, November 16, 2026Nov 16

THE INFLUENCE GAME: Drug lobby’s health care win

ALAN FRAM

Associated Press Writer

EDITOR’S NOTE – An occasional look at how influence is exercised in Washington.

WASHINGTON – Chalk one up for the pharmaceutical lobby.

The U.S. drug industry fended off price curbs and other hefty restrictions in President Barack Obama’s health care law even as it prepares for plenty of new business when an estimated 32 million uninsured Americans gain health coverage.